SciVision Biotech (Taiwan) Insiders
| 1786 Stock | TWD 92.00 2.90 3.06% |
SciVision Biotech employs about 11 people. The company is managed by 2 executives with a total tenure of roughly 26 years, averaging almost 13.0 years of service per executive, having 5.5 employees per reported executive. Recap of SciVision Biotech's management performance can provide insight into the venture performance.
| Tai Han Insider Gen Director |
| Ru Guo Insider Financial VP |
SciVision |
SciVision Biotech Management Team Effectiveness
The company has return on total asset (ROA) of 0.0331 % which means that it generated a profit of $0.0331 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0952 %, meaning that it generated $0.0952 on every $100 dollars invested by stockholders. SciVision Biotech's management efficiency ratios could be used to measure how well SciVision Biotech manages its routine affairs as well as how well it operates its assets and liabilities.SciVision Biotech Workforce Comparison
SciVision Biotech is number one stock in number of employees category among its peers. The total workforce of Medical Instruments & Supplies industry is presently estimated at about 142. SciVision Biotech holds roughly 11.0 in number of employees claiming about 8% of all equities under Medical Instruments & Supplies industry.
The company has Profit Margin (PM) of 0.26 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.23 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.23. SciVision Biotech Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. SciVision Biotech Price Series Summation is a cross summation of SciVision Biotech price series and its benchmark/peer.
SciVision Biotech Notable Stakeholders
A SciVision Biotech stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as SciVision Biotech often face trade-offs trying to please all of them. SciVision Biotech's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting SciVision Biotech's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
About SciVision Biotech Management Performance
The success or failure of an entity such as SciVision Biotech often depends on how effective the management is. SciVision Biotech management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of SciVision management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the SciVision management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
SciVision Biotech Inc. manufactures and sells hyaluronic acid products in Taiwan. SciVision Biotech Inc.was founded in 2001 and is based in Kaohsiung, Taiwan. SCIVISION BIOTECH operates under Medical Instruments Supplies classification in Taiwan and is traded on Taiwan Stock Exchange.
Please note, the imprecision that can be found in SciVision Biotech's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of SciVision Biotech. Check SciVision Biotech's Beneish M Score to see the likelihood of SciVision Biotech's management manipulating its earnings.
SciVision Biotech Workforce Analysis
Traditionally, organizations such as SciVision Biotech use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare SciVision Biotech within its industry.SciVision Biotech Manpower Efficiency
Return on SciVision Biotech Manpower
| Revenue Per Employee | 46M | |
| Revenue Per Executive | 252.8M | |
| Net Income Per Employee | 9.2M | |
| Net Income Per Executive | 50.9M | |
| Working Capital Per Employee | 50.8M | |
| Working Capital Per Executive | 279.5M |
Additional Tools for SciVision Stock Analysis
When running SciVision Biotech's price analysis, check to measure SciVision Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SciVision Biotech is operating at the current time. Most of SciVision Biotech's value examination focuses on studying past and present price action to predict the probability of SciVision Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SciVision Biotech's price. Additionally, you may evaluate how the addition of SciVision Biotech to your portfolios can decrease your overall portfolio volatility.